The Australian polidocanol (aethoxysklerol) study. Results at 2 years.

摘要: BACKGROUND An ongoing study of the safety and effectiveness polidocanol by 98 investigators in Australia injecting 16,804 limbs over 2 years. OBJECTIVE To evaluate complications compare its with sodium tetra-decyl sulphate (STD) hypertonic saline. METHODS A single-arm prospective as a sclerosant was performed. This compared each investigator's previous experience other sclerosing agents. Patients had either varicose veins or venule ectasias and/or spider (telangiectasia). total were injected investigators. Sclerotherapy performed 0.5% 1% for telangiectasias veins, 3% veins. The sclerotherapy any reported during 2-year period. RESULTS There very few polidocanol. no deaths anaphylaxis. sclerosants considered that superior to STD (85%) saline (84%). Ninety percent less frequent than STD, 80% these severe. Seventy-four fewer side effects saline, 74% severe. CONCLUSIONS Polidocanol is an effective has complications.